News & Analysis on Clinical Trial Services & Contract Research And Development
Applied Genetic Technologies Corporation (AGTC), announced today the initiation of a Phase 1 clinical study to test the safety of AGTC-0106, its investigational gene therapy product for patients with Alpha-1 Antitrypsin deficiency ("Alpha-1").
2005 was a challenging year for contract sales organisations (CSO), with many downsizing their sales teams. However, In2Focus, is bucking the industry trend, and increasing its headcount to meet demand.
GE Healthcare has announced the introduction of Ettan nanoLC, a fully bio-inert, robust, nanoscale peptide separation system that delivers highly reproducible performance and is ideal for 1D-liquid chromatography (LC) proteomics applications upstream...
Nastech Pharmaceutical Company, announced today the expansion of its RNAi therapeutics pipeline by initiating an RNAi therapeutics program targeting influenza and respiratory diseases.
Scientists have found that certain T-cell stimulation could help improve treatment of autoimmune disease and cancer, which could be significant for developing new drug treatments to help patients with autoimmune diseases such as rheumatoid arthritis,...
Anachem has just kicked off a unique new European-wide support and maintenance service for scientific instruments - the first of its kind - aimed to help instrumentation suppliers wanting to grow their sales in Europe.
Scientists have discovered a new way that drugs can attach themselves to DNA, providing a crucial step forward for those who are developing drugs to combat cancer and other diseases. The breakthrough heralds a new way of recognising DNA, which will...